A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling

Por Halai, Reena, Croker, Daniel E., Suen, Jacky Y., Fairlie, David P., Cooper, Matthew A.
Publicado no Biosensors (Basel) (2012)

Derivation of ligands for the complement C3a receptor from the C-terminus of C5a

Por Halai, Reena, Bellows-Peterson, Meghan L, Branchett, Will, Smadbeck, James, Kieslich, Chris A, Croker, Daniel E, Cooper, Matthew A, Morikis, Dimitrios, Woodruff, Trent M, Floudas, Christodoulos A, Monk, Peter N
Publicado no Eur J Pharmacol (2014)

Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950

Por Salla, Manohar, Butler, Mark S., Pelingon, Ruby, Kaeslin, Geraldine, Croker, Daniel E., Reid, Janet C., Baek, Jong Min, Bernhardt, Paul V., Gillam, Elizabeth M. J., Cooper, Matthew A., Robertson, Avril A. B.
Publicado no ACS Med Chem Lett (2016)

A small molecule inhibitior of the NLRP3 inflammasome is a potential therapeutic for inflammatory diseases

Por Coll, Rebecca C., Robertson, Avril A. B., Chae, Jae Jin, Higgins, Sarah C., Muñoz-Planillo, Raúl, Inserra, Marco C., Vetter, Irina, Dungan, Lara S., Monks, Brian G., Stutz, Andrea, Croker, Daniel E., Butler, Mark S., Haneklaus, Moritz, Sutton, Caroline E., Núñez, Gabriel, Latz, Eicke, Kastner, Daniel L., Mills, Kingston H. G., Masters, Seth L., Schroder, Kate, Cooper, Matthew A., O’Neill, Luke A. J.
Publicado no Nat Med (2015)